Read More

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

ADIL

Read More

What’s Going On With Informatica Stock?

Salesforce is reportedly in advanced negotiations to acquire Informatica, according to a Wall Street Journal report from Friday. Reportedly, the discussed acquisition amount is lower than Informatica's recent closing stock price which may be complicating the matter. 

CRM